Rising stroke rates in young adults highlight urgent prevention—manage blood pressure and cholesterol early, address obesity ...

Deaf patients face major gaps in stroke care, from poor ASL health literacy to interpreter barriers, undermining discharge ...

Use of the Psychiatric Collaborative Care Model (CoCM) increased 26-fold nationally among commercially insured patients ...

Researchers at City St. George’s, University of London, have identified a new molecular signature that may explain why ...

The Consolidated Appropriations Act of 2026 features new language that could change the way that pharmacy benefit managers ...

Alteplase, a “clot-buster” medication used to treat ischemic stroke, acute myocardial infarctions, and acute pulmonary ...

Experts discuss the promising future of HER2-targeted therapies, highlighting new treatments and combination strategies for ...

The Consolidated Appropriations Act of 2026 features new language that could change the way that pharmacy benefit managers (PBMs) operate in the US.

An independent predictor of CS-responsive MG was ptosis (OR, 2.13; 95% CI, 1.05-4.32), but this association only remained when AChR antibody–positive status was an independent predictor of CRMG (OR, 2 ...

Senate Democrats are advancing a new prescription drug pricing agenda they say would lower costs for patients, reduce wasteful health care spending, and strengthen US biomedical innovation, while ...

Experts discuss the potential of TKIs like zongertinib and seviberatinib as first-line treatments for HER2-mutant non-small cell lung cancer.

Nurse navigators play a crucial role in managing HER2-targeted therapy side effects, ensuring patient education and early toxicity detection.